CLIA Kit for Complement Component 3 (C3)
ASP; CPAMD1; Complement Protein C3; C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1; C3a anaphylatoxin; Acylation stimulating protein
- Product No.SCA861Ra
- Organism SpeciesRattus norvegicus (Rat) Same name, Different species.
- Sample Typeserum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- Test MethodDouble-antibody Sandwich
- Assay Length2h, 40min
- Detection Range0.27-200ng/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 0.12ng/mL.
- DownloadInstruction Manual
- UOM 48T96T 96T*5 96T*10 96T*100
For more details, please contact local distributors! 821 US$ 821
For more details, please contact local distributors! US$ 3695
For more details, please contact local distributors! US$ 6979
For more details, please contact local distributors! US$ 57470
For more details, please contact local distributors!
This assay has high sensitivity and excellent specificity for detection of Complement Component 3 (C3).
No significant cross-reactivity or interference between Complement Component 3 (C3) and analogues was observed.
Matrices listed below were spiked with certain level of recombinant Complement Component 3 (C3) and the recovery rates were calculated by comparing the measured value to the expected amount of Complement Component 3 (C3) in samples.
|Matrix||Recovery range (%)||Average(%)|
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Complement Component 3 (C3) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Complement Component 3 (C3) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Complement Component 3 (C3) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
|Pre-coated, ready to use 96-well strip plate||1||Plate sealer for 96 wells||4|
|Detection Reagent A||1×120µL||Assay Diluent A||1×12mL|
|Detection Reagent B||1×120µL||Assay Diluent B||1×12mL|
|Substrate A||1×10mL||Substrate B||1×2mL|
|Wash Buffer (30 × concentrate)||1×20mL||Instruction manual||1|
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 100µL Substrate Solution. Incubate 10 minutes at 37°C;
8. Read RLU value immediately.
- Single-component Reagents of Assay Kit
- Lysis Buffer Specific for ELISA / CLIA
- Quality Control of ELISA / CLIA
- CLIA Kit Customized Service
- Disease Model Customized Service
- Serums Customized Service
- TGFB1 Activation Reagent
- Real Time PCR Experimental Service
- Fast blue Protein Stain solution
|Artificial Organs||Experimental Research With Synthetic Copolymer-Coated Cardiopulmonary Bypass Circuits: Inflammatory and Thrombogenicity Analysis Wiley: source|
|Journal of Clinical Immunology||Complement activation contributes to the injury and outcome of kidney in human anti-glomerular basement membrane disease. PubMed: 22941511|
|Lipids in Health and Disease||Beneficial effects of omega-3 fatty acids in the proteome of high-density lipoprotein proteome PubMed: PMC3480889|
|Am J Reprod Immunol||Human IgG Antinuclear Antibodies Induce Pregnancy Loss in Mice by Increasing Immune Complex Deposition in Placental Tissue: In Vivo Study PubMed: 26388133|
|Veterinary Immunology and Immunopathology||Oral administration of heat-inactivated Mycobacterium bovis reduces the response of farmed red deer to avian and bovine tuberculin Pubmed:27032499|
|International Journal of Molecular Sciences||Identification of Serum Peptidome Signatures of Non-Small Cell Lung Cancer Pubmed:27043541|
|Food Chem.||Comparative proteomics of milk fat globule membrane in goat colostrum and mature milk Pubmed:27173528|
|Scientific Reports||Generation of complement protein C3 deficient pigs by CRISPR/Cas9-mediated gene targeting. pubmed:28694465|
|Veterinary Microbiology||The response of red deer to oral administration of heat-inactivated Mycobacterium bovis and challenge with a field strain. pubmed:28888638|
|Proteomics Clinical Applications||iTRAQ‐Based Proteomic Analysis Reveals Protein Profile in Plasma from Children with Autism Pubmed:29274201|
|Nanomaterials||An OMV-Based Nanovaccine Confers Safety and Protection against Pathogenic Escherichia coli via Both Humoral and Predominantly Th1 Immune Responses in … Pubmed: 33233490|
|Diagnostics||Systemic Alterations of Immune Response-Related Proteins during Glaucoma Development in the Murine Model DBA/2J Pubmed: 32585848|
|Scientific Reports||The bovine cumulus proteome is influenced by maturation condition and maturational competence of the oocyte Pubmed: 32555221|
|Int Immunopharmacol||Complement component 3 prevents imiquimod-induced psoriatic skin inflammation by inhibiting apoptosis in mice Pubmed: 32535539|
|Italian Journal of Animal Science||Effects of chitooligosaccharide supplementation on laying performance, egg quality, blood biochemistry, antioxidant capacity and immunity of laying hens during the …|
|Dev Comp Immunol||A deep-sea pathogenic Bacillus subtilis isolate employs different strategies to escape the killing of teleost and murine complements 33545212|
|Animal||Effect of alfalfa hay and starter feed supplementation on caecal microbiota and fermentation, growth, and health of yak calves 33610512|
|British Journal of Pharmacology||The suppression of Brd4 inhibits peripheral plasma cell differentiation and exhibits therapeutic potential for systemic lupus erythematosus|
|Scientific Reports||Maternal Serum Proteomic Profiles of Pregnant Women With Type 1 Diabetes 34940989|
|Catalog No.||Related products for research use of Rattus norvegicus (Rat) Organism species||Applications (RESEARCH USE ONLY!)|
|RPA861Ra01||Recombinant Complement Component 3 (C3)||Positive Control; Immunogen; SDS-PAGE; WB.|
|PAA861Ra01||Polyclonal Antibody to Complement Component 3 (C3)||WB; IHC; ICC; IP.|
|LAA861Ra71||Biotin-Linked Polyclonal Antibody to Complement Component 3 (C3)||WB; IHC; ICC.|
|LAA861Ra81||FITC-Linked Polyclonal Antibody to Complement Component 3 (C3)||WB; IHC; ICC; IF.|
|MAA861Ra21||Monoclonal Antibody to Complement Component 3 (C3)||WB; IHC; ICC; IP.|
|SEA861Ra||ELISA Kit for Complement Component 3 (C3)||Enzyme-linked immunosorbent assay for Antigen Detection.|
|SCA861Ra||CLIA Kit for Complement Component 3 (C3)||Chemiluminescent immunoassay for Antigen Detection.|
|LMA861Ra||Magnetic Luminex Assay Kit for Complement Component 3 (C3)||Magnetic Luminex Assay for Antigen Detection.|